Postponed: Cystatin C at IFCC EuroMedLab 2021

22. Nov 2021 | 6 min read

Postponed: Cystatin C at IFCC EuroMedLab 2021

Meet us at EuroMedLab - Booth #201

Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab 2021 promoting our turbidimetric cystatin C immunoassay. Visit us at booth #201 to learn more.

Cystatin C - Superior Kidney Marker1

More than 4000 journal articles have been published on the clinical relevance of cystatin C since it was discovered as a marker of GFR in 1979 by Dr. Anders Grubb. The rising cost pressures faced by health systems has pushed cystatin C into the forefront of biomarkers that could reduce healthcare costs.

26 years after the first automated assay for cystatin C was developed, Gentian emphasises the unique prognostic and diagnostic value of cystatin C as a marker that:

  • Is independent of muscle mass2-8
  • Estimates GFR without race-adjustment9
  • Correlates well with GFR within the “creatinine blind area”10
  • Identifies chronic kidney disease (CKD) earlier than creatinine-based eGFR11
  • Ensures safety and efficacy of medications with a narrow therapeutic index9,12


Visit us at our booth #201

Visit us during opening hours or book a meeting in advance through marketing@gentian.com. 


mailchimp images


Gentian Cystatin C Immunoassay 

  • Particle-Enhanced Turbidimetric Immunoassay
  • With avian antibodies for reduced interference 
  • Can be applied on most automated platforms
  • ERM-DA471/IFCC standardised
  • FDA510 (k) cleared and CE-marked

 

Contact us now for more information

 

validation kit cystatin c

 

References: 

  1. Dharnidharka VR et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysisAm J Kidney Dis. 2002
  2. 1–226.KDIGO Guidelines 2012 published in Kidney International Supplements Vol3 Issue 1, Jan 2013
  3. NCIC Clinical guideline (CG182) updated jan 2015 section 2.1 https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started.
  4. Tangri N et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rateKidney Int. 2011
  5. Grubb A. Cystatin C is Indispensable for Evaluation of Kidney DiseaseEJIFCC. 2017
  6. Björk J  et al. Validation of standardized creatinine and cystatin C GFR estimating equations in a large multicentre European cohort of childrenPediatr Nephrol. 2019
  7. Inker LA  et al. Estimating glomerular filtration rate from serum creatinine and cystatin C [published correction appears in N Engl J Med. 2012
  8. Schaeffner ES et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012
  9. Ebert N, Shlipak MG. Cystatin C is ready for clinical useCurr Opin Nephrol Hypertens. 2020
  10. Lindström V. Low molecular mass proteins as markers for renal function and dialysis efficiency. Doctoral Dissertation, Lund University, 2013.
  11. Murty MS et al. Serum cystatin C as a marker of renal function in detection of early acute kidney injuryIndian J Nephrol. 2013
  12. Frazee E et al. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement ProjectAm J Kidney Dis. 2017

You may also read


Webinar: The biomarker calprotectin - for plasma and serum

Nov 30, 2021

Webinar: The biomarker calprotectin - for plasma and serum

Biomarker for early detection of the inflammatory response to infections Calprotectin is one of the earliest..

Webinar: Cystatin C - Now is the time

Nov 29, 2021

Webinar: Cystatin C - Now is the time

Recommending increased use of cystatin C Cystatin C is less susceptible to factors that affect muscle mass..

Postponed: Cystatin C at IFCC EuroMedLab 2021

Nov 22, 2021

Postponed: Cystatin C at IFCC EuroMedLab 2021

Meet us at EuroMedLab - Booth #201 Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab..